Patients are not given sufficient information about the novel status of a procedure, possible uncertainties or potential risks when deciding to go ahead with the procedure, research led by the ...
Sham controls can be integral to CV device trials, providing a unique way to overcome the placebo effect, but they also present an ethical minefield of concerns that merit close consideration, a new ...
A landmark 2019 CMS ruling opened the door for ASCsto receive Medicare reimbursement for certain angioplasty and stenting procedures, and a new study suggests these procedures are just as safe in ASCs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results